Wilson B C
Hamilton Regional Cancer Centre, Ontario, Canada.
Ciba Found Symp. 1989;146:60-73; discussion 73-7. doi: 10.1002/9780470513842.ch5.
With the development of new photosensitizers that have enhanced photoactivation at longer wavelengths than haematoporphyrin derivative, new considerations arise in the light source and delivery systems and in the techniques for physical dosimetry and in vivo optical measurements in photodynamic therapy. The limitations and future potential of solid-state laser sources are presented. The relationships between photosensitizer photoactivation characteristics and the effective photodynamic treatment volume are developed and discussed quantitatively. The problems in defining and measuring the photodynamic dose are examined, and potential techniques for measuring the factors involved in this are evaluated with emphasis on noninvasive approaches which may be used clinically.
随着新型光敏剂的开发,其在比血卟啉衍生物更长的波长下具有增强的光活化作用,光动力疗法中的光源和输送系统、物理剂量测定技术以及体内光学测量技术出现了新的考量因素。本文介绍了固态激光源的局限性和未来潜力。定量地建立并讨论了光敏剂光活化特性与有效光动力治疗体积之间的关系。研究了定义和测量光动力剂量时存在的问题,并评估了测量其中涉及因素的潜在技术,重点是可用于临床的非侵入性方法。